Select Committee on Home Affairs Written Evidence


Annex H

THE EFFECTIVENESS OF DRUG TREATMENT PROGRAMMES

INTRODUCTION

  1.  For prisoners and probationers, as in the community (outside the CJS), drug treatment can be very effective both healthwise and in terms of reducing offending. Treatment is not a panacea—as many drop out as complete courses of treatment, and not all of those who complete do so successfully. However, treatment is still highly cost-effective. A conclusion from NTORS, the National Treatment Outcomes Research Study of programmes in the community, is that for every extra £1 spent, £3 is saved in terms of victimisation/crime and (to a much lesser degree) the CJS.

DRUG TREATMENT FOR PRISONERS

  2.  In the last few years, some 60 drug treatment programmes have been established for prisoners in England and Wales. There are now over 4,300 prisoner entrants to therapeutic communities and rehabilitation programmes. With around 100,000 sentenced prisoners arriving/departing every year, this is still a comparatively modest level of provision, given reasonable assumptions about levels of need. Approximately three-quarters of prisoners have used illicit drugs in the previous year before going to prison. Of these, two-thirds (ie half of all prisoners) have used heroin, cocaine or crack—the most costly and damaging drugs. Roughly the same proportion considered themselves to have a drug problem (Liriano & Ramsay, 2003, analysing the Criminality Survey 2000). However, while many prisoners reporting a drug problem were interested in treatment, which is an important pre-requisite, at least as many were not interested.

  3.  So, in conclusion, estimates for the proportion of all newly-arrived prisoners who can usefully or theoretically be targeted for treatment range from roughly 40% (considering themselves to have a drug problem) to close to three-quarters (recent drug users, but not necessarily using drugs on a regular basis). This latter option is a less sensible one.

RESEARCH RESULTS AND METHODOLOGIES (DRUGS AND OFFENDING BEHAVIOUR PROGRAMMES)

  4.  Current models of evaluation typically take the form of retrospective reconviction studies. These are usually single-focus evaluations of individual programmes examined in isolation. They do not explain why programmes work or fail to work for different participants. There is a basic difficulty in that prisoners generally have a multiplicity of needs, which are best addressed holistically. In other words, both interventions and their evaluations should ideally be multi-modal. It is also fair to say that interventions do not necessarily work mechanistically—in particular, they need to be followed up by further support or after-care or additional treatment.

  5.  There is one drugs-evaluation for which various published evaluations exist: the RAPt[10] programme. Those studies are presented in Chapter 6 of Home Office Research Study 267 (Prisoners' Drug Use and Treatment: Seven Research Studies, 2003). Those evaluations show that RAPT graduates achieved significant reductions in their drug use and offending on their release, compared variously with their own expected outcomes, or with other groups of broadly comparable prisoners, or with those starting but not completing treatment. These positive results are important in that RAPt is the longest-accredited drug treatment programme for prisoners. They may partly reflect the fact that RAPt places a strong emphasis on after-care, both in prison and on release.

  6.  However, it is important to bear in mind that such studies are not able to take account of "selection bias", the fact that those electing for treatment may be so strongly motivated that they are almost bound to perform better than expected for offenders with their criminal careers. There is another bias, in the opposite direction, that is also hard to take account of: that when comparisons are made with groups of broadly comparable offenders, these are not necessarily drug-using offenders, yet given that drug-users have a worse prognosis on release, this means that a relatively severe test is being imposed, in this kind of evaluation.

  7.  The obvious alternative is random allocation to (or not to) treatment as a precursor to any evaluation. However, this faces ethical and practical difficulties that have proved difficult in prisons (Farrington et al, 2002). More fundamentally, random-controlled trials (RCTs) are typically conceived of as single-issue evaluations—and the point has already been made that there are limits to the value of any one intervention or programme in isolation from other responses.

  8.  While there will always be a need to do single-issue evaluations, which can be relatively cost-effective, the North American research literature suggests that these should ideally be complemented by at least a very occasional multi-modal evaluation, carried out prospectively rather than retrospectively. The value of such multi-modal studies, which are not cheap because they involve repeated surveys of people both in custody and on release as well as analysis of reconviction data, is that they can take account of prisoners' different levels of motivation and other relevant factors. There is even a sense in which some of the value of RCTs can be embodied in multi-modal approaches: prisoners with comparable motivation may not all get the same opportunities to receive treatment.

THE BROADER PICTURE: THE VALUE OF DRUG TREATMENT IN THE COMMUNITY

  9.  The value of a prospective, longitudinal research study is helpfully illustrated by NTORS (National Treatment Outcome Research Study), the first and only UK study of treatment outcomes for problem drug users. Over 1,000 drug users were followed for five years, during and after different types of treatment. Substantial decreases in drug use were observed, as were important reductions in acquisitive crime—particularly for heroin users. As noted above, treatment was shown to be highly cost-effective.

  10.  The value of drug treatment in addressing both drug use and offending is also confirmed by evaluations of DTTOs (Drug Treatment and Testing Orders). The latest report (by Hough et al, 2003) shows that, while only a third of those probationers receiving this type of community punishment completed their orders, their two-year reconviction rate (53%) was substantially lower than the rate for those whose order was revoked (91%). The authors concluded that, with DTTOs, the key to success lies in retaining people on their orders.



10   Rehabilitation for Addicted Prisoners trust-a "12-Step" drug treatment programme. Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2005
Prepared 7 January 2005